Market Cap (In KRW)
22.84 Billion
Revenue (In KRW)
2.6 Billion
Net Income (In KRW)
-19.26 Billion
Avg. Volume
583.64 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1131.0-6340.0
- PE
- -
- EPS
- -
- Beta Value
- 0.154
- ISIN
- KR7229000005
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Sung-Rai Cho
- Employee Count
- -
- Website
- https://www.gencurix.com
- Ipo Date
- 2017-04-05
- Details
- Gencurix Inc. provide diagnostic solutions in South Korea. Its products include GenesWell BCT, a prognosis diagnostic test for breast cancer; GenesWell ddEGFR Mutation Test, a companion test for lung cancer; Droplex, a genetic test that detects DNA mutations; eDX, an early diagnosis for cancer with liquid biopsy; GenePro COVID-19 detection test; GenePro SARS-CoV-2 Test kit; GenoCTC (circulating tumor cell isolator); GenePro LAMP test solution for rapid, convenient and simple detection of various infectious diseases; and GenePro LAMP Cycler, a device for loop-mediated isothermal amplification. The company was founded in 2011 and is headquartered in Seoul, South Korea.
More Stocks
-
300664
-
2149BaTelab Co Ltd
2149
-
EVERESTOEverest Organics Limited
EVERESTO
-
2484Demae-Can Co.,Ltd
2484
-
DUELLDuell Oyj
DUELL
-
NDTP
-
9556INTLOOP Inc.
9556
-
AZNAstraZeneca PLC
AZN